C. Robledo

发表

Molecular Characterization of the Region 7q22.1 in Splenic Marginal Zone Lymphomas

J. Martinez-Climent, M. Piris, Jesús M. Hernández, 2011, PloS one.

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

J. Hernández-Rivas, A. Kohlmann, Mónica Sala-Valdés, 2017, British Journal of Cancer.

A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts.

J. Hernández-Rivas, A. Kohlmann, C. Robledo, 2017, Leukemia research.

Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression

N. Gutiérrez, M. Delgado, C. Robledo, 2012, Pharmacogenetics and genomics.

Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes

J. Hernández-Rivas, A. Kohlmann, M. D. del Cañizo, 2016, PloS one.

Clinical applications of BAC array-CGH to the study of diffuse large B-cell lymphomas.

J. Hernández, C. Robledo, J. García, 2013, Methods in molecular biology.

Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B‐cell lymphomas

Marcos González, J. Hernández, M. Piris, 2009, Cancer.

Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling.

J. Hernández, J. García, N. Gutiérrez, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Frequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype–phenotype relationships

B. Martínez-Delgado, Á. Zaballos, M. Posada, 2019, Journal of Human Genetics.

SLUG (SNAI2) overexpression in embryonic development

P. A. Pérez-Mancera, I. González-Herrero, T. Flores, 2006, Cytogenetic and Genome Research.

Calreticulin mutations are exceedingly rare in patients with myelodysplastic syndromes with myelofibrosis

C. Robledo, L. Zamora, F. Ramos, 2017, Annals of Hematology.

Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse

J. Hernández-Rivas, N. de Las Heras, J. Ribera, 2020, Diagnostics.

Analysis of chromosomal imbalances in an elderly woman with a giant cell tumour

J. Hernández, T. Flores, C. Robledo, 2005, Virchows Archiv.

Onychomatricoma: genome-wide analyses of a rare nail matrix tumor.

C. Robledo, J. García, Á. Santos-Briz, 2011, Journal of the American Academy of Dermatology.

Expression of VAV1 in the tumour microenvironment of glioblastoma multiforme

Jesús M. Hernández, J. Couceiro, X. Bustelo, 2012, Journal of Neuro-Oncology.

Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL

J. Hernández-Rivas, J. Galende, C. Robledo, 2017, European journal of haematology.

The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose‐intensive chemotherapy including rituximab

L. Escoda, M. Tormo, J. Hernández-Rivas, 2016, British journal of haematology.

Chromosomal abnormalities are related to location and grade of osteoarthritis.

J. Hernández, N. Gutiérrez, C. Robledo, 2004, Osteoarthritis and cartilage.

Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia

J. Hernández-Rivas, C. Robledo, J. García, 2014, European journal of haematology.

Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome

J. Hernández-Rivas, J. Rodríguez, J. Labrador, 2016, PloS one.

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome

J. Hernández-Rivas, J. García, F. Sánchez-Guijo, 2009, Leukemia.

Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

C. Robledo, E. Salido, M. Abáigar, 2021, Annals of Hematology.

Integration of Global Spectral Karyotyping, CGH Arrays, and Expression Arrays Reveals Important Genes in the Pathogenesis of Glioblastoma Multiforme

C. Elosua, Jesús M. Hernández, N. Gutiérrez, 2012, Annals of Surgical Oncology.

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia

Marcos González, J. Hernández-Rivas, A. Kohlmann, 2017, Journal of Hematology & Oncology.

MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.

Marcos González, J. Hernández-Rivas, J. Rodríguez, 2016, Leukemia research.

Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group

L. Arenillas, M. Tormo, L. Florensa, 2017, American journal of hematology.

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

S. Rives, J. Hernández-Rivas, A. Minguela, 2020, Journal of personalized medicine.

Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis

M. Tormo, J. Hernández-Rivas, E. Barragán, 2016, Oncotarget.

Frequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype–phenotype relationships

B. Martínez-Delgado, Á. Zaballos, M. Posada, 2019, Journal of Human Genetics.

A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia

F. Bosch, P. Abrisqueta, I. Marugán, 2015, PloS one.

Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profiling.

J. García, N. Gutiérrez, J. Hernández, 2012 .

CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells

C. Robledo, S. Monzón, Santiago Josa, 2023, International journal of molecular sciences.

Sensitivity, Reproducibility and Clinical Utility Of Next-Generation Sequencing (NGS) for BCR-ABL1 Kinase Domain Mutation Screening: Results From The CML Work Package Of The Iron-II (Interlaboratory RObustness Of Next-Generation Sequencing) International Study

A. Kohlmann, T. Haferlach, T. Lion, 2013 .